The Center for Neurological and Neurodevelopmental Health and the Clinical Research Center of NJ

Neurology

Mark Mintz, MD is an expert in the field of Neurology. He attended Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. He received awards:"Voorhees Business Person of the Year", "2013 Philadelphia Future 50 Award", "Top Physicians", "Top Docs For Kids", "Health Care Professional of the Year-2009", "Fellow of the College of Physicians of Philadelphia", "Top Docs", "The Best Doctors in America: Northeast Region", "11 citations for outstanding didactic and clinical teaching of medical students", "National Health Service Corps Medical School Scholarship", "Magna Cum Laude" and "Who's Who In American Education". Mark Mintz has written publications. He has 9 publications published with PubMed. The lastest publication is: 'A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years ...' Mark Mintz accepts all Medicare patients.

Publications

---

• The use of second-generation antipsychotics and the changes in physical growth in children and Adolescents with perinatally acquired HIV.
• Neurocognitive effects of adjunctive levetiracetam in children with partial-onset Seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
• Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and Adolescents with HIV.
• Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and Adolescents.
• The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
• Atomoxetine treatment of ADHD in children with comorbid Tourette Syndrome.
• Severe neuropathy with leaky connexin32 hemichannels.
• A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years ...

Schools

---

• UmdnjRobert Wood Johnson Medical School

• Alber Einstein College Of MedicineMontefiore Medical Center

• University Of Medicine and Dentistry Of New JerseyNew Jersey Medical School

Procedures Preformed

---

• Behavior Modification
• Cognitive Assessment
• Developmental Evaluation
• EEG (Electroencephalogram)
• View All

Conditions Treated

---

• Absence Seizure
• Adolescent Depression
• Alzheimer's Disease
• Anxiety
• View All

Doctors Specialties

---

• Developmental-Behavioral Pediatrics
• Neurodevelopmental Disabilities
• Pediatric Neurology
• Neurology

Accepted Insurances

---

Awards

---

• Voorhees Business Person of the Year
• 2013 Philadelphia Future 50 Award
• Top Physicians
• Top Docs For Kids
• Health Care Professional of the Year-2009
• Fellow of the College of Physicians of Philadelphia
• Top Docs
• The Best Doctors in America®: Northeast Region
• 11 citations for outstanding didactic and clinical teaching of medical students
• National Health Service Corps Medical School Scholarship
• Magna Cum Laude
• Who's Who In American Education

Education

---

• UMDNJ-New Jersey Medical School
• Albert Einstein - Montefiore Medical Center
• Rutgers Robert Wood Johnson Medical School

Hospital

---

• Hackensack University Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Andrew S. Blackstone, DO
	Dr. Madeline A. Chadehumbe, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog